Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

BACKGROUND: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19 vaccine regimen in this population. METHODS: We performed a prospective longitudinal study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Massa, Filippo, Cremoni, Marion, Gérard, Alexandre, Grabsi, Hanen, Rogier, Lory, Blois, Mathilde, Couzin, Chloé, Hassen, Nadia Ben, Rouleau, Matthieu, Barbosa, Susana, Martinuzzi, Emanuela, Fayada, Julien, Bernard, Ghislaine, Favre, Guillaume, Hofman, Paul, Esnault, Vincent L.M., Czerkinsky, Cecil, Seitz-Polski, Barbara, Glaichenhaus, Nicolas, Sicard, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573385/
https://www.ncbi.nlm.nih.gov/pubmed/34763205
http://dx.doi.org/10.1016/j.ebiom.2021.103679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573385/
https://www.ncbi.nlm.nih.gov/pubmed/34763205
http://dx.doi.org/10.1016/j.ebiom.2021.103679

Ejemplares similares